Sun Pharmaceutical Industries has received US health regulator’s approval for generic docetaxel injection, used in treating cancer, in the American market. The company’s subsidiary - Sun Pharma Advanced Research Company - has received abbreviated new drug approval from US Food and Drug Administration for Docefrez in strength of 20 mg/vial and 80 mg/vial. The company’s product is indicated for metastatic breast cancer, lung cancer and hormone refractory metastatic prostate cancer. This product could potentially give the company over $50 million over a year.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1669.05 |
| Dr. Reddys Lab | 1222.65 |
| Cipla | 1230.70 |
| Zydus Lifesciences | 931.80 |
| Lupin | 2323.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: